Pro5® MHC Class I Pentamers

Lin Y, et al. (2026). “Regulatory T cell-derived TGF-β signaling governs the differentiation and maintenance of tumor-infiltrating bystander CD8+ T cells.“Cell Reports, 2026; 45. https://doi.org/10.1016/j.celrep.2026.117189

A. Varin, et al. (2026). “A Subset of Pro-inflammatory CXCL10+ LILRB2+ Macrophages Derives From Recipient Monocytes and Drives Renal Allograft Rejection.” Advanced Science13, no. 10 (2026): e21294.
https://doi.org/10.1002/advs.202521294

Lim, K.H.J., et al. (2026) “Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunity.” Nat Immunol 27, 72–81 (2026). https://doi.org/10.1038/s41590-025-02354-w

Jones TA, et al. (2026) “Targeting the novel immune checkpoint KLRG1 is markedly therapeutic
against cancer through multiple lymphocyte subsets.” Journal for ImmunoTherapy of Cancer 2026;14:e013869. https://doi.org/10.1136/jitc-2025-013869

Zhu, A., et al. (2025) “Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs.” Nat Immunol 26, 459–472 (2025). https://doi.org/10.1038/s41590-024-02072-9

Anne R. Diers, et al. (2025). “Dynamic tracking of tumor microenvironment modulation using Kaede photoconvertible transgenic mice unveils new biological properties of viral immunotherapy.” Cancer Research Communications 2025. https://doi.org/10.1158/2767-9764.CRC-24-0434

Li S, et al. (2025). “Tumor Cell–Intrinsic Decr2 Regulates Ferroptosis and Immunotherapy Efficacy.” Cancer Immunol Res 1 August 2025; 13 (8): 1284–1302. https://doi.org/10.1158/2326-6066.CIR-24-0519

Sanlorenzo, M., et al. (2025) “Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells.” Nat Cancer 6, 175–193 (2025). https://doi.org/10.1038/s43018-024-00889-9

Nguema L, et al. (2024). “Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cells.” eBioMedicine, 2024; 111. https://doi.org/10.1016/j.ebiom.2024.105479

Vieira Antão A, et al. (2024) “Filling two needs with one deed: a combinatory mucosal vaccine
against influenza A virus and respiratory syncytial virus.” Front. Immunol. 15:1376395. https://doi.org/10.1038/s41541-024-00912-1

Wang Z, et al. (2024). “IL-1α is required for T cell-driven weight loss after respiratory viral infection.”
Mucosal Immunology, 2024; 17, 272-287. https://doi.org/10.1016/j.mucimm.2024.02.005

van Zyl DG, et al. (2024) “Poly(2-methyl-2-oxazoline) as a polyethylene glycol alternative for lipid nanoparticle formulation. “Front. Drug Deliv. 4:1383038. https://doi.org/10.3389/fddev.2024.1383038

Delacher M., et al. (2024). “The effector program of human CD8 T cells supports tissue remodeling.” J Exp Med. 2024 Feb 5;221(2):e20230488. doi: 10.1084/jem.20230488. Epub 2024 Jan 16. https://doi.org/10.1084/jem.20230488

Tanaka, M., et al. (2024). “HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.” Int. J. Mol. Sci. 2024, 25, 6858. https://doi.org/10.3390/ijms25136858

Peña-Asensio J., et al. (2024) “HBsAg level defines different clinical phenotypes of HBeAg(−) chronic HBV infection related to HBV polymerase-specific CD8+ cell response quality.” Front. Immunol. 15:1352929. https://doi.org/10.3389/fimmu.2024.1352929

Serafini B. (2024). “EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus and its niche may escape immune surveillance.” 10.1016/j.jneuroim.2024.578314. https://doi.org/10.1016/j.jneuroim.2024.578314

Fan J., et al. (2024). “IL-15-induced CD38+HLA-DR+CD8+ T cells correlate with liver injury via NKG2D in chronic hepatitis B cirrhosis.” Clin Transl Immunology. 13(10):e70007. doi: 10.1002/cti2.70007. https://doi.org/10.1002/cti2.70007

Jung S, et al. (2022) “The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses” Cell Reports, 2022; 40. https://doi.org/10.1016/j.celrep.2022.111138

Jung, J.H., et al. (2021). “SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.” Nat Commun 12, 4043 (2021). https://doi.org/10.1038/s41467-021-24377-1

Rha M, et al. (2020) “PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19.” Immunity, 2020; 54, 44-52.e3. https://doi.org/10.1016/j.immuni.2020.12.002

Peng, Y., et al. (2020). “Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.” Nat Immunol 21, 1336–1345 (2020). https://doi.org/10.1038/s41590-020-0782-6